Cargando…
Notch pathway regulates osimertinib drug‐tolerant persistence in EGFR ‐mutated non–small‐cell lung cancer
Osimertinib is a third‐generation epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitor (TKI) that has shown marked antitumor activity in patients with EGFR‐mutated non–small‐cell lung cancer (NSCLC). However, these effects are transient and most patients develop resistance. Reversible d...
Autores principales: | Takahashi, Hirofumi, Sakakibara‐Konishi, Jun, Furuta, Megumi, Shoji, Tetsuaki, Tsuji, Kosuke, Morinaga, Daisuke, Kikuchi, Eiki, Kikuchi, Junko, Noguchi, Takuro, Hatanaka, Kanako C., Hatanaka, Yutaka, Shinagawa, Naofumi, Konno, Satoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067397/ https://www.ncbi.nlm.nih.gov/pubmed/36411521 http://dx.doi.org/10.1111/cas.15674 |
Ejemplares similares
-
Risk of bleeding associated with transbronchial biopsy using flexible bronchoscopy in patients with echocardiographic or chest CT evidence of pulmonary hypertension
por: Takashima, Yuta, et al.
Publicado: (2022) -
Successful Application of Edoxaban in the Treatment of Venous Thromboembolism Recurrence in a Patient with Non-small Cell Lung Cancer after Tumor Shrinkage
por: Shoji, Tetsuaki, et al.
Publicado: (2018) -
A case of radio-insensitive SMARCA4-deficient thoracic undifferentiated carcinoma with severe right heart failure
por: Ito, Shotaro, et al.
Publicado: (2021) -
DLL3 regulates the migration and invasion of small cell lung cancer by modulating Snail
por: Furuta, Megumi, et al.
Publicado: (2019) -
Nivolumab-induced immune thrombocytopenia in a patient with malignant pleural mesothelioma
por: Sakakibara-Konishi, Jun, et al.
Publicado: (2020)